U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 14

Variation
Gene
(Protein Change)
Type
(Consequence)
ConditionClassification, Review status
EGFR
Variation
Inflammatory skin and bowel disease, neonatal, 2
GPathogenic
EGFR
Variation
Inflammatory skin and bowel disease, neonatal, 2
GPathogenic
EGFR
(C273S +3 more)
Single nucleotide variant
(missense variant)
Inflammatory skin and bowel disease, neonatal, 2
GUncertain significance
EGFR
(K173Q +2 more)
Single nucleotide variant
(missense variant +1 more)
EGFR-related lung cancer
+2 more
GUncertain significance
EGFR
Single nucleotide variant
(intron variant)
not provided
+1 more
GBenign
EGFR
Single nucleotide variant
(synonymous variant)
Inflammatory skin and bowel disease, neonatal, 2
+2 more
GBenign
EGFR
(P297S +3 more)
Single nucleotide variant
(missense variant)
Inflammatory skin and bowel disease, neonatal, 2
+2 more
GUncertain significance
EGFR
Single nucleotide variant
(synonymous variant +1 more)
Inflammatory skin and bowel disease, neonatal, 2
+4 more
GBenign
EGFR
Single nucleotide variant
(synonymous variant)
not provided
+4 more
GBenign
EGFR
(G428D +3 more)
Single nucleotide variant
(missense variant)
EGFR-related lung cancer
GPathogenic
EGFR
(S1162N +3 more)
Single nucleotide variant
(missense variant)
Inflammatory skin and bowel disease, neonatal, 2
+2 more
GBenign/Likely benign
EGFR
(R521K +3 more)
Single nucleotide variant
(missense variant)
not specified
+4 more
GBenign
EGFR, EGFR-AS1
Single nucleotide variant
(non-coding transcript variant +1 more)
Hereditary cancer-predisposing syndrome
+6 more
GBenign
EGFR, EGFR-AS1
(T790M +3 more)
Single nucleotide variant
(non-coding transcript variant +1 more)
erlotinib response - Efficacy
+2 more
Gdrug response
OOncogenic
Format
Items per page
Sort by
Choose Destination